Haemonetics Corp. (HAE)
80.15
-0.83
(-1.02%)
USD |
NYSE |
Dec 31, 16:00
80.16
0.00 (0.00%)
After-Hours: 20:00
Haemonetics EPS Diluted (Quarterly): 0.8116 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| Dentsply Sirona, Inc. | -2.140 |
| Solventum Corp. | 7.218 |
| DexCom, Inc. | 0.7035 |
| Masimo Corp. | -1.859 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 38.68M |
| Revenue (Quarterly) | 327.32M |
| Total Expenses (Quarterly) | 288.63M |
| Enterprise Value | 4.680B |
| Gross Profit Margin (Quarterly) | 56.04% |
| Profit Margin (Quarterly) | 11.82% |
| Earnings Yield | 4.28% |
| Operating Earnings Yield | 6.02% |
| Normalized Earnings Yield | 4.285 |